logo
Can We Talk?: Families open up about managing mental health

Can We Talk?: Families open up about managing mental health

Daily Telegraph25-06-2025
Don't miss out on the headlines from Family Health. Followed categories will be added to My News.
It's a rare sight in modern families. Three generations of Emma Styles' family live under one roof and gather for dinner – device-free – most nights of the week.
The mother-of-two says open communication across the generations is a priority in their home, and they use meal times as an important way to check in.
Mrs Styles, 47, her husband Matt and their teenage daughters moved in with her parents in 2023 after her father Martin was diagnosed with dementia.
'It's very important to talk openly about what's going on, otherwise things can get to a point where they can't easily be remedied,' she said.
'We sit down for dinner and use the rose, bud, thorn exercise, where we all share what was good about our day, what didn't go our way, and what we are looking forward to tomorrow.'
She said she has always been able to confide in her mum, Barbara Deacy, 72, and her dad, who recently passed away.
And she has always encouraged her daughters, Suraya, 15, and Kenya, 18, to open up to her too.
Emma Styles with her daughters Suraya (15) and Kenya (17). Picture: Tim Joy
'Mum's health isn't the best now, but she's always been there for me when I've had mental health issues or relationship breakdowns,' she said.
'And she comes to me now with anything that's going on, big or small.
'My parents have always been a big support. I always want Suraya and Kenya to know they can come to me with anything awful that happens, and keep those communication lines open.'
But she sets boundaries around what she shares about her life with her daughters, and avoids talking about finances or her own mental health as she doesn't want to be a 'burden'.
Kenya, 18, said she felt comfortable talking to her parents about personal issues, from relationships to bullying and peer pressure.
'Mum will always listen and console me if I need it, and acknowledge that I have a problem,' she said.
'Depending on the situation, she will validate my feelings or tell me how to move on and what to do next.'
She said the stress of Year 12, including schoolwork, bullying issues and a break-up, would have been even harder without her parents' support.
'My grades would have plummeted, and I probably would have ended up almost dropping out of school,' she said.
Her sister Suraya, 15, turned to her mum and online therapists when struggling with issues including fitting in with peers and social media dynamics.
'WhatsApp and friend groups and chats can cause some stress, and I'll go to mum because she gets it,' she said.
But both teens said it was harder to be open with their grandma, even before her health began deteriorating.
'I can't imagine talking to my grandma about serious stuff like my friends or ex-boyfriend… I don't think she'd understand what I'm going through,' said Kenya.
'I think it's a generational barrier. She's had different life experiences to me, and communication is different because she grew up without social media.'
She said it would be helpful if older generations listened more to young people and showed 'a willingness to be in a vulnerable state with you'.
Can We Talk? is a News Corp awareness campaign, in partnership with Medibank, helping Australian families better tackle mental wellbeing. To follow the series and access all stories, tips and advice, visit our new Health section.
Originally published as Can We Talk?: Families open up about managing mental health
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Microplastics are in our food, water and air. How can we minimise our exposure to them?
Microplastics are in our food, water and air. How can we minimise our exposure to them?

ABC News

time7 hours ago

  • ABC News

Microplastics are in our food, water and air. How can we minimise our exposure to them?

The scourge of plastic pollution will continue to grow, at least for now, after talks to strike a global treaty fell apart this month. It was the sixth round of such negotiations in three years, but despite a last-ditch scramble on Friday, delegates could not reach agreement. Meanwhile, new research continues to expose plastic's quiet presence in our food, tap water and the air we breathe. A study published last month found higher-than-expected levels of inhalable plastic particles in a handful of apartments and cars in France. Recent Australian research found even compost contains teeny plastic fragments, which may eventually make their way into agricultural soils and food crops. These are a couple of the latest studies into microplastics: fragments or fibres of plastic between a micron (one millionth of a metre) up to 5 millimetres in size. Microplastics can be created as a result of larger pieces of plastic shedding or breaking apart, or be added to products, such as plastic powders added to some cosmetics. Along with microplastics, there are also nanoplastics. These are plastic particles less than a micron wide. For context, a human hair is about 50 microns in diameter. Being so tiny, nanoplastics might more easily infiltrate human cells and tissues such as our blood, "so they're the ones scientists are interested in", University of Queensland microplastics researcher Cassandra Rauert said. So considering micro- and nanoplastics are everywhere, from the summit of Everest to the deepest ocean, how can we minimise our exposure without living in a cave? The short answer is: we don't yet know. Part of that stems from the fact that we don't know a whole lot about microplastics in general, such as where they come from, how many are in our environment, how they might get into our body, what they do once they're in there, and how much we excrete. "Unfortunately, microplastics is a very new field of research," Dr Rauert said. Compared to other everyday pollutants such as pesticides, scientists don't have a good handle on the potential effects of microplastic or nanoplastic exposure. And current techniques to identify micro- and nanoplastics in various organs "are not perfect". "We really don't have good data showing that plastics are ending up in our brains or our liver or our placenta and things like that. "There's a lot of reactive media to those studies and it's causing a lot of concern, which is very understandable, but … we really don't have a good grip on if plastics are actually getting into our bodies yet." So what do we know? More research needs to be done, but it seems that micro- and nanoplastics can generate inflammation, Dr Rauert said. It's not just the physical presence of plastic particles in the body that may affect our health — it's also the chemicals they bring with them, she added: "You're getting a double hit when you're exposed to these things." Such chemicals can be picked up by plastic particles from the environment, or are additives used during manufacturing that make the plastic more malleable, for instance. These chemicals can disrupt hormones, and "there's evidence coming out now that they're linked to type 2 diabetes", Dr Rauert said. "It's these chemicals that we … are more concerned about exposure to [than the plastic itself]." Despite not yet having definitive evidence that microplastics cause harm to our health, researchers suggest avoiding them as much as possible. That can be hard, considering just how much plastic is all around us all the time. When it comes to food, there is some good news: there's probably less plastic in what we eat than originally feared. One of Dr Rauert's students surveyed food a typical Australian would buy from the supermarket and found low concentrations of nano- and microplastics in them. Any plastic present in food probably comes from the packaging around it. But it's what we do with the food when we bring it home that can contribute to microplastic levels, Dr Rauert added. "If you're using a plastic chopping board, every time you use that [and] you can see it's deforming and degrading as you're using it, there are small pieces of plastic that are going to be coming off that board and end up in the food you're eating." The same goes with plastic ladles and the like. So if possible, try to use wooden chopping boards and metal or wood utensils. Tap water is a potentially bigger source of microplastics than food. These plastic particles can come from any number of sources, from the water treatment process to the PVC pipes that plumb your home. Putting tap water through a filter may be helpful in removing some of the larger microplastics, Dr Rauert said, even if some of the smaller microplastics and nanoplastics slip through. "I reckon in the next couple of years there probably will be some [microplastic-filtering devices] on the market." The air inside our home and the dust that settles on surfaces could well be teeming with micro- and nanoplastics small enough to get into our lungs. Synthetic textiles such as polyester and nylon shed tiny fragments and fibres of plastic, and they are found everywhere from furniture to clothes to manchester and carpet. "A lot of our carpets are polypropylene, so when pieces of the carpet are just wearing off over time, then you're getting small pieces of polypropylene in the air," Dr Rauert said. It might sound boring, but wiping down dusty surfaces and vacuuming regularly can reduce microplastics in your home. Another big source of microplastics in the home, Dr Rauert said, is the clothes dryer, especially if you use it to dry synthetic materials. As they tumble in the hot air, synthetic materials release plastic fibres that aren't captured by the dryer filter. And if that hot air blows out into your home, it carries all those fibres with it. It's often not available to people in apartments, but having a dryer that exhausts to the outside environment instead of inside your house can help keep microplastics down, as can avoiding using the dryer for synthetic materials altogether. Generally, the air outside has fewer microplastics than indoor air, especially in winter when windows might remain closed to keep the warmth in. So it's worth periodically opening windows and doors to ventilate the air in your home and let microplastics out. While we can take individual action to keep our home environment as microplastic-free as possible, plastic pollution will continue to be a problem until large-scale changes are made, such as tougher action from governments, Dr Rauert said. "There are small things we can do, but we really need a bigger, collective global effort to try and really cut down the amount of unnecessary plastic that we keep on producing every year. "You don't actually consider how much plastic you use in your everyday life. It's always there. It's just you don't think about it." For more on microplastics, check out the full episode of Lab Notes.

PainChek's AI app set to transform pain detection beyond words
PainChek's AI app set to transform pain detection beyond words

News.com.au

time7 hours ago

  • News.com.au

PainChek's AI app set to transform pain detection beyond words

PainChek App uses AI to analyse facial muscle movements and detect pain in adults with unreliable communication skills FDA clearance forecast in October could make PainChek only US-approved pain assessment tool for dementia in aged care As part of a product expansion PainChek launches Infant app in Australia to detect pain in babies aged 1-12 months How can carers and medical professionals accurately assess pain in someone who can't reliably communicate? Available on smartphones and tablets, PainChek (ASX:PCK) has developed an app that uses AI facial recognition to analyse facial muscle movements and detect pain – even when it isn't obvious – designed for people with dementia or cognitive impairment who have limited communication. Following a series of clinical studies in target markets PainChek has been regulatory-cleared in Australia, Canada, the EU, New Zealand, Singapore, Malaysia, and the UK. CEO and managing director Philip Daffas told Stockhead US Food and Drug Administration (FDA) de novo (new device) clearance was expected in early October with PainChek set to be the only regulated product in the world's largest healthcare market to assess pain for people with dementia or cognitive impairment in aged care. "PainChek has AI technology that assesses for nine facial expressions, known as action units, that indicate pain," he said. "There's five other steps guiding the user such as a nurse to use their clinical judgement for other observations to indicate pain such as movement or sounds a person may be making. "Its a cumulative score so the more indicators present the higher severity of pain with clinical observation key and AI good to pick up microfacial features indicating pain." Daffas said the study for US FDA clearance had to be done across all American patient populations, providing further validation for the app, which had already undertaken more than 12 million pain assessments. "In our FDA study we showed we could replicate it with different American populations from African Americans, Hispanic etc and the system worked well across all those groups," he said. "The US is an initial US$100 million annual market opportunity for PainChek." Borne out of technology from Curtin University The technology started out of Western Australia's Curtin University School of Pharmacy with the idea coming from PainChek's now chief scientific officer Professor Jeff Hughes. "He was doing rounds as a pharmacist in an aged care facility and thought they're not managing pain properly, particularly in people with dementia, and there must be a better way," Daffas said. "He went to a PhD student at the university and told him he wanted a thesis on making a better pain assessment tool for people living with dementia who can't verbalise, which was the genesis of the product." With extensive global experience in medical devices Daffas was contacted by a friend on the innovation board of Curtin University to evaluate the tool and see if it was commercially viable. "I thought it had legs so started working with Jeff and the team and six months later there was an initiative in WA to take it out of the university and backdoor list it on the ASX through a mining stock going nowhere," Daffas said. "They approached me to come on as CEO and managing director to get everything going and help raise the capital. "We took the product out of the uni in October 2016 and it was a prototype with still a lot of work to be done including clinical studies and regulatory clearance but the genesis of the product was there." It was originally called EPAT, which was the university's code name for the product standing for Electronic Pain Assessment Technology. "When we got going the company and product name was switched to PainChek." From Cochlear to PainChek – growing next ASX healthcare leader Originally from the UK Daffas spent his entire career working with companies developing novel medical devices. "I've worked in the UK, US, Germany and Australia – I've had a very patient wife and children," he said. "The first job I stumbled into after finishing uni was with IVAC which was the first company to make an infusion pumps and innovators of electronic thermometers, now big products. "I later worked for Roche Diagnostics in Germany, which were innovators in blood glucose monitoring to help people with diabetes manage the disease at home." Daffas joined Aussie-grown global hearing implant leader Cochlear (ASX:COH) in the late 1990s. "They had recently listed and weren't quite profitable and I came in to head up their European, Middle East and African business based out London," he said. It was during his time at Cochlear and moving to Australia to head its global marketing that Daffas was inspired to establish an Australian medical device company. "I developed this appetite to start something from scratch in Australia and take it to the world so when PainChek came up I thought this is the opportunity," he said. Daffas said through his extensive experience he came to understand how medical devices were successfully developed from scratch. "The model we follow for PainChek is very much a Cochlear model of establishing the product and validating it in the domestic market," he said. "Secondly, we established a team in the UK, New Zealand and Canada in parallel which are recognised as high value markets. "Only then once the product is established did we aim to enter much bigger markets like the US." Daffas said he could make PainChek profitable tomorrow if he was merely focused on Australia, however his vision is to grow the company into the next ASX healthcare success story. "We want to establish a new global brand like your Cochlear and ResMed (ASX:RMD) and to do that you must have shareholders who understand that is the journey and are supportive, which fortunately we do," he said. Daffas said it took Cochlear 20 years to be profitable from when they started and he thinks PainChek will be profitable in around 10 years. "We're eight down already and are on track to be profitable in the next two years." PainChek in more than 30% of Australian aged care facilities In Australia more than 30% of aged care facilities are using PainChek to manage pain in their residents. "There are around 200,00 aged care beds in Australia and we have close to 70,000 beds under contract," Daffas said. "In the UK we have about 40,000 beds." Daffas said its revenue model is based on annual recurring revenue with the cost $50 per bed per annum. "So in an aged care facility with 100 beds that is $5000 per year," he said. "Our smallest customer has 50 beds and our largest has 7500 beds so our business model is ARR and we are up to about $5.5 million now and we're getting very strong retention rates." Daffas said the market for PainChek was strong with a need to manage pain effectively in a growing dementia population. "There's 150 million people living with dementia in the world and it is looking to double in next five years as we age and there is yet no cure," he said. Taking guesswork out of infant pain Any parent can relate to the angst of identifying if their baby is in pain. As part of its product expansion PainChek has launched its PainChek Infant app in Australia, which identifies and detects six facial action units indicative of pain in infants aged one month to 12 months. It is now commercially available on the App Store for home use by parents. "While the adult product is more B2B and sold into aged care, home care or hospitals for use by nurses, carers and clinicians the PainChek Infant app is more directed to parents," Daffas said. "There are something like 400 million children who are pre-verbal in the world at any one time and there is 150 million babies born each year globally to first time parents. He said PainChek Infant was an addition in the repertoire of tools for parents such as a baby monitor or digital thermometer. "It doesn't tell the parent what is causing the pain just like a thermometer doesn't tell what is causing the fever," he said. "It just shows there is clear indicators this baby is in pain or distress and often there's an overlap but it requires intervention whether cuddling the baby, giving medication or seeking medical advice." Daffas said the company was also developing a product for toddlers aged one to three. "With infants and toddlers it is just a three second analysis of the face and no other behaviour factors you need to observe," he said. PainChek is also working on a research project with the West Australian government for a PainChek app to assess pain for children living with disabilities like cerebral palsy. "That is a much more complex product," he said. The PainChek share price is up ~45% YTD.

Bindi Irwin sparks endometriosis conversation after sharing her story
Bindi Irwin sparks endometriosis conversation after sharing her story

ABC News

time2 days ago

  • ABC News

Bindi Irwin sparks endometriosis conversation after sharing her story

Bindi Irwin is urging women not to accept endometriosis pain as normal. The 27-year-old's post on social media in 2023 detailing her diagnosis with endometriosis has been liked more than one million times. This week, Ms Irwin stated that after 13 years of fighting for answers, 51 endometriosis lesions, a cyst, two surgeries, and a hernia, it was now time to heal. She said she felt "utterly ashamed" of her pain as her endometriosis symptoms were constantly dismissed. Like many women, Ms Irwin said this eroded her self-esteem, and she was speaking out to help reduce the stigma and secrecy around discussing the condition. Endometriosis is a disease in which tissue similar to the lining of the uterus grows in other parts of the body. About one in 10 of those assigned female at birth have endometriosis. Ebony Nykiel, 26, from Queensland's Sunshine Coast, said Bindi's post resonated with her. She said it took 13 years for her diagnosis of endometriosis. Ms Nykiel said she had her first period at 10, and from the start, her painful symptoms were dismissed by others. Her eventual diagnosis was "bittersweet". She said it was validating to learn she "wasn't crazy" but that she was left with limited treatment options. Ms Nykiel said it wasn't just a woman's issue. "It's everyone's issue," she said. Ms Irwin said she was "slowly, slowly" regaining her strength. "I can FINALLY (sic) say that I'm feeling better. Genuinely healing. I can function in everyday life without wanting to throw up or pass out from the pain," she wrote on social media. "I cannot express the gravity of my emotions as I am beginning to recognise myself again. "I felt utterly ashamed as a teenager and young adult being told that my pain was just part of being a woman. "I felt lesser. I felt hurt. I felt weak." She said others should not have to endure isolation along with the trauma caused by endometriosis. "Young girls and women shouldn't feel alone with pain in the driver's seat of their lives," Ms Irwin said. "We need to take away the stigma of talking about women's health. It's time to have open discussions and make change on a global scale." Jessica Spain, a social worker and PhD candidate at the University of the Sunshine Coast, is researching the experiences of women and girls in regional Queensland accessing an endometriosis diagnosis. She said it was "so common" for them to be dismissed or for their pain to be normalised, misdiagnosed, or mistreated. Miss Spain said it could take six to eight years to be diagnosed. Accessing care, she said, was even more challenging for those who were Aboriginal and Torres Strait Islander, transgender, non-binary, living with a disability, or in a regional area. "The stigma around it has kept women under wraps for hundreds and thousands of years," she said. "Females are the experts in their own bodies and we know when something's wrong." She said women were often told they were being dramatic or that it was stress-related. Miss Spain said she found Ms Irwin's post empowering. "Endometriosis doesn't discriminate," Miss Spain said. "It's so powerful for her to speak up about that because that will resonate with so many people." Monica Forlano, from Endometriosis Australia, said it was a full-body and potentially lifelong health condition. She said, historically, the female body was not studied in the same way as men's bodies. "It essentially just comes down to medical misogyny," she said. "We know so little about it, it's still a mystery, an enigma." She said that through more funding, research, and awareness, the future was likely brighter for those living with the disease. Ms Forlano said she hoped to see endometriosis discussed more widely in schools with boys and girls of all ages. "It shouldn't be a life-defining condition. People can thrive," Ms Forlano said. "They just need to be seen and heard and listened to."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store